Lost in Translation: Participation in Cancer Clinical Trials for Patients With Limited English Proficiency

Author:
Joseph M. Unger
Search for other papers by Joseph M. Unger in
Current site
Google Scholar
PubMed
Close
 PhD

Disclosures: The author has disclosed having no financial interests, arrangements, affiliations, or commercial interestswith themanufacturers of any products discussed in this article or their competitors.

Correspondence: Joseph M. Unger, PhD, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N, M3-C102, PO Box 19024, Seattle, WA 98109-1024. Email: junger@fredhutch.org

View associated content

  • Collapse
  • Expand
  • 1.

    Murthy VH, Krumholz HM, Gross CP. Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA 2004;291:27202726.

  • 2.

    Unger JM, Fleury M. Nationally representative estimates of the participation of cancer patients in clinical research studies according to the commission on cancer. J Clin Oncol 2021;39:74.

    • Search Google Scholar
    • Export Citation
  • 3.

    Unger JM, Vaidya R, Hershman DL, et al. Systematic review and meta-analysis of the magnitude of structural, clinical, and physician and patient barriers to cancer clinical trial participation. J Natl Cancer Inst 2019;111:245255.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4.

    Comis RL, Miller JD, Aldigé CR, et al. Public attitudes toward participation in cancer clinical trials. J Clin Oncol 2003;21:830835.

  • 5.

    Unger JM, Hershman DL, Till C, et al. “When offered to participate”: a systematic review and meta-analysis of patient agreement to participate in cancer clinical trials. J Natl Cancer Inst 2021;113:244257.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 6.

    Jorge S, Masshoor S, Gray HJ, et al. Participation of patients with limited English proficiency in gynecologic oncology clinical trials. J Natl Compr Canc Netw 2023;21:2732.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 7.

    Muthukumar AV, Morrell W, Bierer BE. Evaluating the frequency of English language requirements in clinical trial eligibility criteria: a systematic analysis using ClinicalTrials.gov. PLoS Med 2021;18:e1003758.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 8.

    Basch E, Reeve BB, Mitchell SA, et al. Development of the National Cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). J Natl Cancer Inst 2014;106:dju244.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 9.

    Minasian LM, Unger JM. What keeps patients out of clinical trials? JCO Oncol Pract 2020;16:125127.

  • 10.

    Loree JM, Anand S, Dasari A, et al. Disparity of race reporting and representation in clinical trials leading to cancer drug approvals from 2008 to 2018. JAMA Oncol 2019;5:e191870.

    • PubMed
    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 405 405 405
PDF Downloads 170 170 170
EPUB Downloads 0 0 0